Celine ALRIC - Profile on Academia.edu (original) (raw)
Papers by Celine ALRIC
Role des tyrosine kinases cytosoloques et membranaires dans la signalisation du recepteur b2 de la bradykinine : etude sur la cellule mesangiale
Le but de notre travail a ete de mettre en evidence l'implication des tyrosine kinases (tk) d... more Le but de notre travail a ete de mettre en evidence l'implication des tyrosine kinases (tk) dans la signalisation des recepteurs b2 de la bradykinine (bk) sur les cellules mesangiales en culture. La mesure de l'activite enzymatique tk nous a permis de decrire une activation et une inhibition des tk. La phase d'activation, rapide et transitoire est mediee par la stimulation de pkc via une proteine gi tandis que la phase d'inhibition plus tardive semble etre stimulee par une autre voie de signalisation. Cet effet biphasique sur les tk est associe a une activation et une inhibition de la phosphorylation sur tyrosine de nombreuses proteines parmi lesquelles nous avons identifie la proteine fak. Parallelement a cette etude nous avons mis en evidence une activation de l'activite tyrosine phosphatase ainsi qu'un effet antiproliferatif de la bk qui pourrait etre lie a l'inhibition des tk. Dans la seconde partie de notre etude, nous avons etudie, sur la cm issue d...
Inhibition of cGMP accumulation in mesangial cells by bradykinin and tyrosine kinase inhibitors
International Journal of Molecular Medicine, 1999
We examined the effect of bradykinin (BK) on the accumulation of cGMP of the mesangial cell (MC),... more We examined the effect of bradykinin (BK) on the accumulation of cGMP of the mesangial cell (MC), a smooth muscle-like cell of the renal glomerulus. BK caused a time- and concentration dependent reduction of the cGMP concentration. In addition, BK inhibited total protein tyrosine kinase (PTK) activity. Two tyrosine kinase inhibitors (TKI) genistein and tyrphostin also reduced the cGMP concentration. The inhibition of BK and TKI were not additive. The inhibition of PTK by BK, mediated through activation of the B2-receptor, was unaffected by inhibitors of Gi/o proteins, phospholipase C, protein kinase C, cyclooxygenase and Ca2+ release from intracellular stores. Only IBMX a broad spectrum inhibitor of phosphodiesterases (PDE) and 8-methoxymethyl IBMX a specific type-1 PDE inhibitor prevented the inhibitory effects of BK and TKI indicating the involvement of type-1 PDE. In addition, BK had no effect on soluble guanylate cyclase (sGC) and nitric oxide synthase activity. In freshly isolated glomeruli, which represent the physiological environment of MC, BK also reduced the cGMP concentration. Like in MC, the inhibitory effect was suppressed by IBMX. These data demonstrate that BK suppresses a PTK-dependent pathway of cGMP production in rat MC at a level downstream of NO synthase and sGC. It is suggested that BK and TKI inhibitors decrease cGMP levels by preventing tyrosine phosphorylation of type-1 PDE activity, thereby leading to enzyme activation.
Immunopharmacology, 1999
The kinin B1-receptor which is absent or expressed at very low levels under physiological conditi... more The kinin B1-receptor which is absent or expressed at very low levels under physiological conditions is strongly induced under inflammatory conditions. It has been shown that B1-receptor induction during inflammation involves interleukin-1b Ž. Ž. Ž. IL-1b production and activation of nuclear factor-kB NF-kB. Since bradykinin BK , the B2-receptor agonist induces IL-1b expression and activates NF-kB, we have analysed the effect of B2-receptor activation in cultured human lung fibroblasts cells on B1-receptor expression by a semiquantitative RT-PCR analysis. Treatment with BK resulted in a significant increase in the expression of B1-receptor mRNA which was abolished by a specific B2-receptor antagonist. This result suggests that B2-receptor activation can prime the expression of B1-receptors. Although the renal localisation of the B2-receptor has been thoroughly studied, nothing is known about the distribution of the B1-receptor in the kidney. Using a combination of microdissection and a semiquantitative RT-PCRrSouthern blot analysis we showed the absence of B1-receptors under physiological conditions in 10 microdissected rat nephron segments. However, 18 h LPS-treatment induced significant expression of the B1-receptor in all, but one segment. These studies provide the first molecular basis for the observed changes in renal haemodynamics after B1-agonist infusion in animal kidney models.
Kidney International, 2002
MC proliferation induced by fetal calf serum (FCS) [16]. These opposite effects of BK have been c... more MC proliferation induced by fetal calf serum (FCS) [16]. These opposite effects of BK have been confirmed by
Canadian Journal of Physiology and Pharmacology, 2002
Several experimental data document an activation of the mitogen-activated protein kinases Erk1 an... more Several experimental data document an activation of the mitogen-activated protein kinases Erk1 and Erk2 by bradykinin (BK), an agonist of the kinin B2receptor (B2R). In contrast, other reports showed an inhibitory modulation of mitogenesis by BK. Therefore, we explored in the isolated glomeruli the effect of B2R activation on the signaling of insulin-like growth factor-1 (IGF-1), platelet-derived growth factor-BB (PDGF-BB), and high glucose (HG), three factors that are believed to be involved in the development of glomerulosclerosis via the phosphorylation of Erk1 and Erk2. We observed that the activation of B2R negatively modulates the phosphorylation of Erk1 and Erk2 induced by IGF-1, PDGF-BB, and HG in the glomerulus. These effects are consistent with the hypothesis of a protective role for BK in the kidney during development of glomerulosclerosis and renal pathologies associated with a hyperproliferative state.Key words: bradykinin, kinin B2receptors, growth factors, hyperglycem...
Renal bradykinin receptors: localisation, transduction pathways and molecular basis for a possible pathological role (review)
International Journal of Molecular Medicine, 1999
Kinins are biologically active peptides that exert their effects by activating two seven transmem... more Kinins are biologically active peptides that exert their effects by activating two seven transmembrane G-protein coupled receptors termed B1 and B2 which have only about 36% of homology. The major kinin peptide under physiological conditions, bradykinin (BK), modulates renal haemodynamics and function. Under physiological conditions most BK effects involve bradykinin B2-receptors. Studies on the intra-cellular transduction pathways, the regulation of the expression and the localisation of these receptors along the nephron, as well as the first studies on transgenic mice models, have allowed to better define the role of these receptors under physiological and pathological conditions. The role of the renal B1-receptor, induced in a variety of pathologies related to inflammation, is poorly understood. Recent investigations on the molecular mechanism of B1-receptor induction and its detailed renal localisation have shown that under inflammatory conditions this kinin receptor might be of importance. B2-receptors are suggested to be involved in part of the renoprotective effects of angiotensin converting enzyme (ACE)-inhibitors in insulin-dependent diabetes. However, ACE-inhibitor treatment, resulting also in an increased B1-agonist concentration might result in homologous induction and activation of the B1-receptor.
Role des tyrosine kinases cytosoloques et membranaires dans la signalisation du recepteur b2 de la bradykinine : etude sur la cellule mesangiale
Le but de notre travail a ete de mettre en evidence l'implication des tyrosine kinases (tk) d... more Le but de notre travail a ete de mettre en evidence l'implication des tyrosine kinases (tk) dans la signalisation des recepteurs b2 de la bradykinine (bk) sur les cellules mesangiales en culture. La mesure de l'activite enzymatique tk nous a permis de decrire une activation et une inhibition des tk. La phase d'activation, rapide et transitoire est mediee par la stimulation de pkc via une proteine gi tandis que la phase d'inhibition plus tardive semble etre stimulee par une autre voie de signalisation. Cet effet biphasique sur les tk est associe a une activation et une inhibition de la phosphorylation sur tyrosine de nombreuses proteines parmi lesquelles nous avons identifie la proteine fak. Parallelement a cette etude nous avons mis en evidence une activation de l'activite tyrosine phosphatase ainsi qu'un effet antiproliferatif de la bk qui pourrait etre lie a l'inhibition des tk. Dans la seconde partie de notre etude, nous avons etudie, sur la cm issue d...
Inhibition of cGMP accumulation in mesangial cells by bradykinin and tyrosine kinase inhibitors
International Journal of Molecular Medicine, 1999
We examined the effect of bradykinin (BK) on the accumulation of cGMP of the mesangial cell (MC),... more We examined the effect of bradykinin (BK) on the accumulation of cGMP of the mesangial cell (MC), a smooth muscle-like cell of the renal glomerulus. BK caused a time- and concentration dependent reduction of the cGMP concentration. In addition, BK inhibited total protein tyrosine kinase (PTK) activity. Two tyrosine kinase inhibitors (TKI) genistein and tyrphostin also reduced the cGMP concentration. The inhibition of BK and TKI were not additive. The inhibition of PTK by BK, mediated through activation of the B2-receptor, was unaffected by inhibitors of Gi/o proteins, phospholipase C, protein kinase C, cyclooxygenase and Ca2+ release from intracellular stores. Only IBMX a broad spectrum inhibitor of phosphodiesterases (PDE) and 8-methoxymethyl IBMX a specific type-1 PDE inhibitor prevented the inhibitory effects of BK and TKI indicating the involvement of type-1 PDE. In addition, BK had no effect on soluble guanylate cyclase (sGC) and nitric oxide synthase activity. In freshly isolated glomeruli, which represent the physiological environment of MC, BK also reduced the cGMP concentration. Like in MC, the inhibitory effect was suppressed by IBMX. These data demonstrate that BK suppresses a PTK-dependent pathway of cGMP production in rat MC at a level downstream of NO synthase and sGC. It is suggested that BK and TKI inhibitors decrease cGMP levels by preventing tyrosine phosphorylation of type-1 PDE activity, thereby leading to enzyme activation.
Immunopharmacology, 1999
The kinin B1-receptor which is absent or expressed at very low levels under physiological conditi... more The kinin B1-receptor which is absent or expressed at very low levels under physiological conditions is strongly induced under inflammatory conditions. It has been shown that B1-receptor induction during inflammation involves interleukin-1b Ž. Ž. Ž. IL-1b production and activation of nuclear factor-kB NF-kB. Since bradykinin BK , the B2-receptor agonist induces IL-1b expression and activates NF-kB, we have analysed the effect of B2-receptor activation in cultured human lung fibroblasts cells on B1-receptor expression by a semiquantitative RT-PCR analysis. Treatment with BK resulted in a significant increase in the expression of B1-receptor mRNA which was abolished by a specific B2-receptor antagonist. This result suggests that B2-receptor activation can prime the expression of B1-receptors. Although the renal localisation of the B2-receptor has been thoroughly studied, nothing is known about the distribution of the B1-receptor in the kidney. Using a combination of microdissection and a semiquantitative RT-PCRrSouthern blot analysis we showed the absence of B1-receptors under physiological conditions in 10 microdissected rat nephron segments. However, 18 h LPS-treatment induced significant expression of the B1-receptor in all, but one segment. These studies provide the first molecular basis for the observed changes in renal haemodynamics after B1-agonist infusion in animal kidney models.
Kidney International, 2002
MC proliferation induced by fetal calf serum (FCS) [16]. These opposite effects of BK have been c... more MC proliferation induced by fetal calf serum (FCS) [16]. These opposite effects of BK have been confirmed by
Canadian Journal of Physiology and Pharmacology, 2002
Several experimental data document an activation of the mitogen-activated protein kinases Erk1 an... more Several experimental data document an activation of the mitogen-activated protein kinases Erk1 and Erk2 by bradykinin (BK), an agonist of the kinin B2receptor (B2R). In contrast, other reports showed an inhibitory modulation of mitogenesis by BK. Therefore, we explored in the isolated glomeruli the effect of B2R activation on the signaling of insulin-like growth factor-1 (IGF-1), platelet-derived growth factor-BB (PDGF-BB), and high glucose (HG), three factors that are believed to be involved in the development of glomerulosclerosis via the phosphorylation of Erk1 and Erk2. We observed that the activation of B2R negatively modulates the phosphorylation of Erk1 and Erk2 induced by IGF-1, PDGF-BB, and HG in the glomerulus. These effects are consistent with the hypothesis of a protective role for BK in the kidney during development of glomerulosclerosis and renal pathologies associated with a hyperproliferative state.Key words: bradykinin, kinin B2receptors, growth factors, hyperglycem...
Renal bradykinin receptors: localisation, transduction pathways and molecular basis for a possible pathological role (review)
International Journal of Molecular Medicine, 1999
Kinins are biologically active peptides that exert their effects by activating two seven transmem... more Kinins are biologically active peptides that exert their effects by activating two seven transmembrane G-protein coupled receptors termed B1 and B2 which have only about 36% of homology. The major kinin peptide under physiological conditions, bradykinin (BK), modulates renal haemodynamics and function. Under physiological conditions most BK effects involve bradykinin B2-receptors. Studies on the intra-cellular transduction pathways, the regulation of the expression and the localisation of these receptors along the nephron, as well as the first studies on transgenic mice models, have allowed to better define the role of these receptors under physiological and pathological conditions. The role of the renal B1-receptor, induced in a variety of pathologies related to inflammation, is poorly understood. Recent investigations on the molecular mechanism of B1-receptor induction and its detailed renal localisation have shown that under inflammatory conditions this kinin receptor might be of importance. B2-receptors are suggested to be involved in part of the renoprotective effects of angiotensin converting enzyme (ACE)-inhibitors in insulin-dependent diabetes. However, ACE-inhibitor treatment, resulting also in an increased B1-agonist concentration might result in homologous induction and activation of the B1-receptor.